Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 211 - Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
Patents for C07D 211 - Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings (37,939)
09/2010
09/22/2010CN101842350A New non-peptide derivatives as bradykinin Bl antagonists
09/22/2010CN101838537A Liquid crystal aligning agent, liquid crystal aligning film, liquid crystal display component, polyamic acid, imide polymer and diamine compound
09/22/2010CN101838248A 1,4-naphthoquinone compounds and application thereof
09/22/2010CN101838233A Preparation method of alvimopan key intermediate
09/21/2010US7799924 Substituted homopiperidine, piperidine or pyrrolidine derivatives
09/21/2010US7799923 Vasopressin receptor antagonists; (4-Benzotriazol-1-yl-piperidin-1-yl)-(5-chloro-1H-indol-2-yl)-methanone; antidepressants, anxiolytic agents; dysmenorrhea, hypertension, inappropriate secretion of vasopressin, liver cirrhosis, nephrotic syndrome, obsessive compulsive disorder
09/21/2010US7799828 selective estrogen receptor modulators such as 4-[(4-Hydroxyphenyl)(3,3,5,5-tetramethylcyclohexylidene)methyl]benzoic acid, used for the treatment of osteoporosis, obesity, breast cancer, depression, vaginal dryness, rheumatoid arthritis, vasomotor symptoms and urogenital or vulvar vaginal atrophy
09/21/2010US7799805 Piperidine carboxylic acid amide derivatives
09/21/2010US7799804 1,2-diarylimidazole-4-carboxamide compounds such as ethanesulfonic acid 4-[2-(2,4-dichlorophenyl)-5-methyl-4-(piperidin-1-ylcarbamoyl)-imidazol-1-yl]phenyl ester, used in the treatment of obesity, psychological and nervous system disorders
09/21/2010US7799803 Hydroxamic acid compounds and methods of use thereof
09/21/2010CA2440559C Novel non-imidazole compounds
09/21/2010CA2436225C N-(arylsulphonyl)beta-amino acid derivatives comprising a substituted aminomethyl group, process for preparing them and pharmaceutical compositions containing them
09/21/2010CA2420568C Pharmaceutically active benzsulfonamide derivatives as inhibitors of protein junkinases
09/21/2010CA2338073C Novel urokinase inhibitors
09/16/2010WO2010104307A2 Pharmaceutical compositions for treating or preventing diseases caused by the translocation of gsk3 from the cell nucleus to the cytoplasm, containing compounds for inhibiting the translocation of gsk3 from the cell nucleus to the cytoplasm
09/16/2010WO2010104306A2 Pharmaceutical compositions for treating or preventing diseases caused by the translocation of gsk3 from the cell nucleus to the cytoplasm, containing compounds for inhibiting the translocation of gsk3 from the cell nucleus to the cytoplasm
09/16/2010WO2010103067A1 Pharmaceutical combination of 5-fluorouracil and derivate of 1,4-dihydropyridine and its use in the treatment of cancer
09/16/2010WO2010065865A3 Sulfonamide derivatives as bcl-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases
09/16/2010WO2010053583A3 Small molecule cd4 mimetics and uses thereof
09/16/2010US20100234604 Process for Making Substituted Aryl Sulfone Intermediates
09/16/2010US20100234603 Process for Making Substituted Aryl Sulfone Intermediates
09/16/2010US20100234433 Glycogen phosphorylase inhibitor compound and pharmaceutical composition thereof
09/16/2010US20100234427 1-phenethylpiperidine derivatives and their use as opioid receptor ligands
09/16/2010US20100234426 Phenylpropionamide Compounds and the Use Thereof
09/16/2010US20100234424 Derivatives of n-phenyl(piperidine-2-yl) methyl benzamide preparation method thereof and applications of same in therapeutics
09/16/2010US20100234409 Amino cyclopentyl heterocyclic and carbocyclic modulators of chemokine receptor activity
09/16/2010US20100234353 Sulfonylamino-derivatives as novel inhibitors of histone deacetylase
09/16/2010US20100234307 Preparation and use of biphenyl amino acid derivatives for the treatment of obesity
09/15/2010EP2228365A1 Pharmaceutical combination of 5-fluorouracil and derivative of 1,4-dihydropyridine and its use in the treatment of cancer
09/15/2010EP2228364A1 Acylsulfonamides as inhibitors of steroid sulfatase
09/15/2010EP2228065A2 Heterocyclo inhibitors of potassium channel function
09/15/2010CN101835750A Cyclopropyl amide derivatives '978
09/14/2010US7795441 Process for preparing imino compounds
09/14/2010US7795438 catalytically hydrogenating a compound [1-benzyl-4-[(5,6-dimethoxy-1-indanon)-2-ylidene]methylpiperidine in the presence of a Raney nickel catalyst in a reaction solvent of toluene or solvent mixture of toluene and methanol to produce donepezil
09/14/2010US7795169 Process for preparing cyanopyridines and suitable catalysts therefor
09/14/2010CA2422805C Retinoids for the treatment of emphysema
09/14/2010CA2394276C Serine protease inhibitors
09/10/2010WO2010101246A1 Piperidine and pyrrolidine derivatives having npy y5 receptor antagonism
09/10/2010WO2010101128A1 Amide compound
09/10/2010WO2010100990A1 Process for the production of nucleophilic adducts by grignard reaction, and nucleophilic addition reactant
09/10/2010WO2010100720A1 Reagent for measurement of cholinesterase activity
09/10/2010WO2010100215A1 SYNTHESIS OF (4aS,7aS)-OCTAHYDRO-1H-PYRROLO[3,4-b]PYRIDINE
09/10/2010WO2009116067A3 Novel derivatives of acyl cyanopyrrolidines
09/10/2010CA2751548A1 Synthesis of (4as,7as)-octahydro-1h-pyrrolo[3,4-b]pyridine
09/09/2010US20100228034 Process for the preparation of keto intermediates
09/09/2010US20100228015 Prodrug derivatives of acids using alcohols with homotopic hydroxy groups and methods for their preparation and use
09/09/2010US20100227886 Selective Serotonin 2A/2C Receptor Inverse Agonists as Therapeutics for Neurodegenerative Diseases
09/09/2010US20100227885 Selective Serotonin 2A/2C Receptor Inverse Agonists as Therapeutics for Neurodegenerative Diseases
09/08/2010EP1841741B1 Piperidine derivatives as prodrugs of potassium channel inhibitors
09/08/2010EP1478624B1 Chemical compounds
09/08/2010CN101827815A Spiroheterocyclic pyrrolidine dione derivatives useful as pesticides
09/08/2010CN101824033A Stereoisomeric compounds and methods for the treatment of gastrointestinal and central nervous system disorders
09/08/2010CN101823994A Antihypertensive compound, synthesis method, application and medicament thereof
09/08/2010CN101048369B Biphenyloxyacetic acid derivatives for the treatment of respiratory disease
09/08/2010CN101039911B Polymorph of N,N-diethyl-4-(3-fluorophenyl-piperidin-4-ylidene-methyl)-benzamide hydrochloride salt
09/07/2010US7790899 Synthesis of N-(4-fluorobenzyl)-N-(1-methylpiperidin-4-yl)-N′-(4-(2-methylpropyloxy)phenylmethyl)carbamide and its tartrate salt and crystalline forms
09/07/2010US7790898 Substituted 3-phenylpiperidine compounds, their preparation and use
09/07/2010US7790897 Graftable hindered amine light stabilizers
09/07/2010US7790882 4-(2-Diphenylphosphanylnaphthalen-1-yl)-phthalazin-1-yl]-(1-phenylethyl)-amine; catalyst selectivity; N,N-Dibenzyl-2-methyl-5-decyn-4-amine from reaction of 1-hexyne, 2-methylbutanal, anddibenzylamine; also hydroboration; cost efficiency; simplification of separation/purification of optical isomers
09/07/2010US7790753 Derivatives of N-[phenyl(alkylpiperidine-2-yl)methyl]benzamide, preparation method thereof and application of same in therapeutics
09/07/2010US7790750 Bicyclic benzamides of 3- or 4-substituted 4-(aminomethyl)-piperidine derivatives
09/07/2010US7790719 used for the treatment of cachexia and other weight loss disorders, such as those resulting from cancer, HIV, old age and anorexia nervosa
09/07/2010US7790715 Organic compounds
09/07/2010CA2438854C Method of preparing non-hydrated fexofenadine hydrochloride and novel crystalline form obtainable by this method
09/02/2010WO2010097802A2 A process for the preparation of etoricoxib
09/02/2010WO2010097374A1 Compounds for use as bradykinin b1 antagonists
09/02/2010WO2010097372A1 Compounds as bradykinin b1 antagonists
09/02/2010WO2010097087A1 Catecholamine derivatives and prodrugs thereof
09/02/2010US20100222589 Deuterated benzo[d][1,3]-dioxol derivatives
09/02/2010US20100222387 3-Fluoro-Piperidine T-Type Calcium Channel Antagonists
09/02/2010US20100222386 Substituted piperidines
09/02/2010US20100222366 Piperidine derivatives as modulators of chemokine receptor activity
09/02/2010US20100222350 Phenyl, pyridine, quinoline, isoquinoline, naphthyridine and pyrazine derivatives
09/02/2010US20100222330 New Compounds
09/02/2010US20100222326 New Heterocyclic Derivatives Useful For The Treatment of CNS Disorders
09/02/2010US20100221189 Contrast agents
09/02/2010CA2759126A1 New compounds
09/01/2010EP2222637A1 Amidine-containing compounds useful as muscarinic receptor antagonists
09/01/2010EP1430027B1 Novel aminoazetidine, -pyrrolidine and -piperidine derivatives
09/01/2010EP1285651B1 Melanin concentrating hormone antagonists
09/01/2010EP1028942B1 Dipeptide nitriles
09/01/2010CN1706841B 1-(4,4-diaryl-3-butene)-piperidine formic acid or its medicine salt, preparation process and application
09/01/2010CN101821262A Gambogic amine, selective trka agonist with neuroprotective activity
09/01/2010CN101821258A Novel preparation process
09/01/2010CN101821256A Novel heterocyclic compounds as mGlu5 antagonists
09/01/2010CN101821237A Novel preparation process
09/01/2010CN101817779A Novel synthesis process of N-benzyl-3-piperidinol, novel nickel-based catalyst and preparation method thereof
09/01/2010CN101817773A Preparation method of chiral alpha-non-natural amino acid
08/2010
08/31/2010US7786332 Prepared via a combinatorial synthesis based on a Suzuki coupling, subsequent halo-demetallation and finally a Suzuki coupling; Suzuki couplings are each carried out with a boronic acid or a boronic acid ester; 5-Bromo-1,3-difluoro-2-[(R)-3-methylpentyl]benzene
08/31/2010US7786316 Metalloprotein inhibitors
08/31/2010US7786308 ethyl 3-(4-((4-fluorophenyl)(methoxycarbonyl)amino)piperidin-1-yl)-8-azabicyclo[3.2.1]octane-8-carboxylate; COPD, asthma, urinary incontinence, glaucoma, Alzheimer's disease; side effects reduction; selectivity for subtypes M1-M5 recptors
08/31/2010US7786307 suchas N-(4(S)-amino-5(S)-hydroxy-2(S)-isopropyl-6-piperidin-1-ylhexyl)-2-(3-methoxypropoxy)benzamide dihydrochloride, used for the treatment of hypertension, cardiovasculr disorders, complications owing to diabetes, vision deffects, hyperaldosteronism, states of anxiety and cognitive disorders
08/31/2010US7786306 Combining a solution comprising a polar, aprotic organic solvent and a mixture of isomers of 2-piperidin-2-yl-ethanol with an aliphatic alcohol solution containing an amino acid resolving agent selected from N-acetyl-L-leucine and N-acetyl-L-methionine; intermediates for cyclin-dependent kinases, CDK
08/31/2010US7786222 Polyamide oligomers and their use
08/31/2010US7786165 Antidiabetic agents; obesity; insulin resistance; neurodegenerative diseases; Alzheimer's disease
08/31/2010US7786141 Treating neurodegenerative diseases, psychological disorders, pain, glaucoma, dru eye, dry mouth, Sjogren's syndrome, asthma, bradycardia, wound healing, gastrointestinal disorders; amide- or urea-functional C5.C5N.C6 SPIRO(INDENE-2,4'-PIPERIDINE) RING structures; selective as to subtypes M1-M5
08/31/2010US7786140 Piperidine derivative having NMDA receptor antagonistic activity
08/31/2010US7786122 use to treat Alzheimer's Disease; (2R)-2-[N-(4-Chlorobenzenesulfonyl)-N-(4-methoxybenzyl)amino]-4-methylpentanoic acid amide for example
08/31/2010US7786121 such as 6-(4-ethoxy-phenyl)-2S-hydroxy-3R-[4-(3-methoxy-phenyl)-piperazine-1-carbonyl]-hexanoic acid hydroxyamide, used for the treatment or prophylaxis of arthritis in mammals
08/31/2010US7786106 such as 3-[(4-methoxybenzoyl)-amino]-2-{[4-(4-methyl-1,4-diazepan-1-yl)benzoyl]amino}phenyl beta -D-glucopyranoside, used as an activated blood coagulation factor X inhibitor; anticoagulants or preventive/therapeutic agents for diseases induced by thrombosis or embolism
1 ... 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 ... 380